XML 69 R53.htm IDEA: XBRL DOCUMENT v3.25.4

Stock Compensation Plans and Other Employee Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2025

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Schedule of Stock Option Activity

A summary of the Plans’ stock option activity for the years ended December 31, 2025, 2024 and 2023 is as follows:

Stock Options						Common Shares						Weighted Average Strike Price						Remaining Contractual Term(1)						Intrinsic Value(2) ($000)
Outstanding at January 1, 2023						68,093						$	41.14
Exercised						(54,993)						40.75
Outstanding at December 31, 2023						13,100						$	42.76					4.2						$	655
Exercisable at December 31, 2023						13,100						$	42.76					4.2						$	655
Outstanding at January 1, 2024						13,100						$	42.76
Exercised						(2,275)						38.00
Outstanding at December 31, 2024						10,825						$	43.76					3.5						$	876
Exercisable at December 31, 2024						10,825						$	43.76					3.5						$	876
Outstanding at January 1, 2025						10,825						$	43.76
Exercised						(5,150)						42.61
Outstanding at December 31, 2025						5,675						$	44.81					2.7						$	539
Exercisable at December 31, 2025						5,675						$	44.81					2.7						$	539
Vested or expected to vest at December 31, 2025						5,675						$	44.81					2.7						$	539

(1)Represents the weighted average contractual remaining life in years.

(2)Aggregate intrinsic value represents the total pretax intrinsic value (i.e., the difference between the Company’s stock price at year end and the option exercise price, multiplied by the number of shares) that would have been received by the option holders if they had exercised their options on the last day of the year. Options with exercise prices above the year end stock price are excluded from the calculation of intrinsic value. The intrinsic value will change based on the fair market value of the Company’s stock.

Schedule of Plans' Restricted and Performance Share Award Activity

A summary of the Plans’ restricted share activity for the years ended December 31, 2025, 2024 and 2023 is as follows:

						2025												2024												2023
Restricted Shares						Common Shares						Weighted Average Grant-Date Fair Value						Common Shares						Weighted Average Grant-Date Fair Value						Common Shares						Weighted Average Grant-Date Fair Value
Outstanding at January 1						880,866						$	90.95					746,123						$	79.60					610,155						$	73.21
Granted						262,521						132.46						407,046						99.89						270,855						88.06
Vested and issued						(224,769)						94.65						(241,415)						70.41						(121,534)						65.90
Forfeited or canceled						(30,220)						110.10						(30,888)						95.26						(13,353)						83.68
Outstanding at end of year						888,398						$	101.63					880,866						$	90.95					746,123						$	79.60
Vested, but deferred, at year end						102,218						$	55.59					100,610						$	54.46					98,919						$	53.58

A summary of the Plans’ performance-based stock award activity, based on the target level of the awards, for the years ended December 31, 2025, 2024 and 2023 is as follows:

						2025												2024												2023
Performance Shares						Common Shares						Weighted Average Grant-Date Fair Value						Common Shares						Weighted Average Grant-Date Fair Value						Common Shares						Weighted Average Grant-Date Fair Value
Outstanding at January 1						454,017						$	93.57					553,026						$	79.69					545,379						$	70.30
Granted						88,310						134.57						111,469						100.47						189,355						92.36
Added by performance factor at vesting						75,461						96.51						96,952						58.78						23,925						62.82
Vested and issued						(230,957)						95.26						(295,644)						58.69						(186,344)						62.67
Forfeited or canceled						(9,074)						105.85						(11,786)						95.97						(19,289)						81.84
Outstanding at end of year						377,757						$	102.38					454,017						$	93.57					553,026						$	79.69
Vested, but deferred, at year end						13,335						$	41.21					21,759						$	44.51					29,020						$	45.88

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration